IND - Investigational New Drug

IND - Investigational New Drug

Parkinson's disease, PD, (DA01)
Sponsors:
BlueRock Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumours, EDIT-201
Discontinued


Sponsors:
Editas Medicine 
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine